News
CacoReady in the literature
Our partners from University of Messina published Antioxidant and Anti-Inflammatory Activity of...
Review of available cell-based in vitro models to evaluate intestinal permeability
In vitro models are commonly used and wildly accepted in research stages that investigate several...
ReadyCell visits FarmaForum
Our collaborators Carla Sapienza and Marta Ollé are attending Farmaforum Madrid to discuss last...
Drug Drug interaction studies in preclinical stage, reduces unexpected adverse events rate in clinical trails
Drug-drug interactions are the most common cause of adverse events during clinical stages in...
The evaluation of drug interactions in preclinical stages optimizes novel drug development
Drug-drug interactions (DDI) are an important risk factor for polymedicated patients, as they can...
Role of pharmacological efflux receptors in cancer treatment resistance
Clinical evidence revealed that multi-drug resistance (MDR) is one of the major pharmacological...
Recommended cell-based in vitro testing to assess BCRP protein-mediated transport
Efflux transporters are membrane proteins often involved in poor absorption and low oral...
3rd SCI-RSC Symposium on Transporters in Drug Discovery and Development
ReadyCell scientists shared their expertise ane experience on the impact of pharmacologically...
Why evaluate MDR1 receptor affinity in CNS pharmacokinetic assays?
The pharmacological implications in blood-brain barrier permeability assays. Drug delivery to the...
BioPrintIA
ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology...
MDCK II cells overexpressing MDR1 protein. A must assay for drug development.
The multidrug resistance protein 1, MDR1 is an efflux transporter that plays an important role in...
Pharmacology 2020 Event
ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in...
Caco-2 Permeability Assay Protocol
Culturing Caco-2 cells in Transwell plates is considered the reference in vitro technique to...
Discover how in vitro Caco-2 kits help you evaluate novel therapeutic molecules
Cellular models are the most used in vitro technique for novel drug studies during preclinical...
Readycell’s gratitude message
Due to the current situation and special circumstances, ReadyCell’s team would like to thank all...
Gelatinous matrix, an innovative solution for in vitro cell preservation
In vitro mammalian cells, such as Caco-2 or MDCKII, are widely used in scientific research and...
PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism
The liver and the kidneys have clearly defined various physiologic functions, their role as...
The latest #FDA guidance on in vitro drug-drug interactions is finally out!
Among other things, the agency explains that DDIs are a critical factor in a drug’s overall...
Meet us at BioAsia 2020 in India
ReadyCell is happy to announce that its team will be attending this year’s BioAsia Conference...
ReadyCell at “The In Vitro Choice” Meeting
ReadyCell speaking at The In Vitro Choice Josep Oriol Nicolás, ex-CEO at ReadyCell, participated...
ReadyCell is proud to receive Nexel in Barcelona
Receiving South Korean partner in Barcelona The Readycell team was glad to welcome Nexel’s CEO Dr....
ReadyCell is proud to receive SOLVO Biotechnology in Barcelona
ReadyCell S.L. was proud to recently welcome our colleagues and partners from SOLVO...
Participating in the Nordic Life Science Days 2018 in Stockholm, Sweden
Going to Stockholm to meet the life science industry ReadyCell has started the last quarter of...
Participating in DDI 2018 in Seattle, USA
Crossing the Atlantic for excellent R&D ReadyCell is committed to keep track of new...
Participating in BIOUSA 2018 in Boston, USA
Developing new trans-Atlantic partnerships June of 2018 has been an important month for ReadyCell,...
Participating in BioJapan 2017 in Yokohama
Internationalization is a core value of our business ReadyCell’s representatives participated in...
ReadyCell visits India as part of Catalan Commercial Mission
ReadyCell going to India to develop new business opportunities. ReadyCell joined two weeks ago a...
ReadyCell will attend CPhI Worlwide
Meet ReadyCell at CPhI Worlwide! ReadyCell will attend to the CHpI Worldwide convention in...
ReadyCell Partnering in China
Developing new international partnerships After different contacts along 2013, last month...
ReadyCell at ADME & Predictive Toxicology Meeting
Join us at the Annual ADME & Predictive Toxicology meeting in Barcelona Select Biosciences...
ReadyCell joins Catalonia Bio
ReadyCell has recently joined Catalonia Bio the Catalan Association of Biotechnologic Companies....
CacoReady Batch #500 Released!
Congratulations to ReadyCell’s Production Team for achieving the release of the batch number 500...